Lindsley Kristina, Nichols Jason J, Dickersin Kay
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Cochrane Database Syst Rev. 2013 Apr 30;4(4):CD007742. doi: 10.1002/14651858.CD007742.pub3.
Hordeolum is a common, painful inflammation of the eyelid margin that is usually caused by bacterial infection. The infection affects oil glands of the eyelid and can be internal or external. In many cases, the lesion drains spontaneously and resolves untreated; however, the inflammation can spread to other ocular glands or tissues, and recurrences are common. If unresolved, acute internal hordeolum can become chronic or can develop into a chalazion. External hordeola, also known as styes, were not included in the scope of this review.
The objective of this review was to investigate the effectiveness and safety of nonsurgical treatments for acute internal hordeolum compared with observation or placebo.
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2012, Issue 7), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE, (January 1950 to July 2012), EMBASE (January 1980 to July 2012), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to July 2012), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 26 July 2012.
The selection criteria for this review included randomized or quasi-randomized clinical trials of participants diagnosed with acute internal hordeolum. Studies of participants with external hordeolum (stye), chronic hordeolum, or chalazion were excluded. Nonsurgical interventions of interest included the use of hot or warm compresses, lid scrubs, antibiotics, or steroids compared with observation, placebo, or other active interventions.
Two review authors independently assessed the references identified by electronic searches for inclusion in this review. No relevant studies were found. The reasons for exclusion were documented.
No trials were identified for inclusion in this review. Most of the references identified from our search reported on external hordeola or chronic internal hordeola. The few references specific to acute internal hordeolum reported mostly recommendations for treatment or were reports of interventional case series, case studies, or other types of observational study designs and were published more than 20 years ago.
AUTHORS' CONCLUSIONS: We did not find any evidence for or against the effectiveness of nonsurgical interventions for the treatment of hordeolum. Controlled clinical trials would be useful in determining which interventions are effective for the treatment of acute internal hordeolum.
睑腺炎是睑缘常见的疼痛性炎症,通常由细菌感染引起。感染累及眼睑的皮脂腺,可为内睑腺炎或外睑腺炎。在许多情况下,病变可自行破溃引流,无需治疗即可痊愈;然而,炎症可蔓延至其他眼腺或组织,且复发很常见。如果不消退,急性内睑腺炎可转为慢性或发展成睑板腺囊肿。外睑腺炎,也称为麦粒肿,不在本综述范围内。
本综述的目的是研究与观察或安慰剂相比,非手术治疗急性内睑腺炎的有效性和安全性。
我们检索了Cochrane系统评价数据库(CENTRAL,其中包含Cochrane眼科和视力组试验注册库)(《Cochrane图书馆》2012年第7期)、Ovid MEDLINE、Ovid MEDLINE在研及其他未索引引文、Ovid MEDLINE每日更新、Ovid OLDMEDLINE(1950年1月至2012年7月)、EMBASE(1980年1月至2012年7月)、拉丁美洲和加勒比地区卫生科学文献数据库(LILACS)(1982年1月至2012年7月)、对照试验元注册库(mRCT)(www.controlled-trials.com)、ClinicalTrials.gov(www.clinicaltrials.gov)和世界卫生组织国际临床试验注册平台(ICTRP)(www.who.int/ictrp/search/en)。在电子检索试验时,我们未使用任何日期或语言限制。我们最后一次检索电子数据库是在2012年7月26日。
本综述的入选标准包括诊断为急性内睑腺炎的参与者的随机或半随机临床试验。排除外睑腺炎(麦粒肿)、慢性睑腺炎或睑板腺囊肿参与者的研究。感兴趣的非手术干预措施包括与观察、安慰剂或其他积极干预措施相比,使用热敷或温敷、眼睑擦洗、抗生素或类固醇。
两位综述作者独立评估通过电子检索确定的参考文献是否纳入本综述。未找到相关研究。记录了排除的原因。
未确定有试验可纳入本综述。我们检索到的大多数参考文献报道的是外睑腺炎或慢性内睑腺炎。少数专门针对急性内睑腺炎的参考文献大多是治疗建议,或是干预性病例系列、病例研究或其他类型观察性研究设计的报告,且发表时间超过20年。
我们未找到支持或反对非手术干预治疗睑腺炎有效性的任何证据。对照临床试验有助于确定哪些干预措施对治疗急性内睑腺炎有效。